Category Specific RSS

Creso Pharma

Melodiol moves to clear debt with $12m asset fire sale

In early 2024, Melodiol Global Health (ASX: ME1), formerly known as Creso Pharma, faced scrutiny from the ASX, regarding corporate…

1 year ago

Melodiol Global Health reports revenue growth amid wider acceptance of medicinal cannabis products

Recreational cannabis use has been a global topic for debate in the past few years but cannabinoids, a naturally occurring…

1 year ago

Dr Pickles to soothe the pain with $21m takeover not looking so rosy for Sierra Sage Herbs

With just four months of operating cash in the bank according to last month’s quarterly report, cannabis company Creso Pharma…

3 years ago

Little Green Pharma to demerge its medicinal psychedelics business

There is an increasingly growing body of research globally into the use of psychedelic medicines to treat various health conditions.…

4 years ago

Creso Pharma enters US medicinal cannabis market via $21m Colorado acquisition

Putting behind them the drama of 2021 which resulted in their former Chairman’s offices being raided by Australian Federal Police,…

4 years ago

Could Creso’s psychedelics solve Australia’s $10.6 billion problem?

According to the Australian Department of Health, half of us will experience some form of mental illness in our lifetime.…

4 years ago